Aquilegia pubiflora
Aquilegia pubiflora · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Aquilegia pubiflora is a botanical species that has garnered scientific interest due to its diverse array of biological activities, including antimicrobial, antioxidant, and cytotoxic properties. Research focusing on the plant's leaves has utilized various extraction methods, specifically producing preparations known as AP$_{DW}$, AP$_{E}$, AP$_{EA}$, and AP$_{M}$. These leaf extracts serve as rich sources of significant phytochemicals, most notably chlorogenic acid and the flavones isoorientin, isovitexin, and orientin. The presence of these specific chemical compounds is believed to drive the plant's therapeutic potential across different biological models. Consequently, studying these preparations provides crucial insights into the chemical profile and pharmacological utility of this species.
- Synonyms
- Aquilegia Pubiflora Var. Hazarica · Aquilegia Pubiflora Var. Mussooriensis · 5 more
- Common names
- Not available
- Family
- Ranunculaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Synonyms
Aquilegia pubiflora is a taxonomically complex species characterized by several recognized synonyms. Within botanical records, it is frequently identified as Aquilegia kurramensis. The plant's classification also encompasses various forms, including Aquilegia pubiflora var. hazarica and Aquilegia pubiflora var. mussooriensis. Furthermore, it has been categorized under the broader umbrella of Aquilegia vulgaris as both subspecies pubiflora and variety mussooriensis. These shifting nomenclatures highlight the intricate evolutionary relationships inherent to this specific columbine.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Aquilegia pubiflora is a distinctive member of the kingdom Plantae. Within this vast biological kingdom, the species is classified under the class Equisetopsida. It belongs to the specific order Ranunculales, which helps define its evolutionary lineage. Furthermore, this plant is nested within the family Ranunculaceae. Ultimately, it is categorized under the well-known genus Aquilegia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Ranunculaceae |
| Genus | Aquilegia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Aquilegia pubiflora exhibits a diverse geographic range that spans across several distinct ecological regions. In the temperate zones of Asia, this species is notably found throughout Western Asia and Afghanistan. Its presence extends significantly into the tropical regions of the Indian Subcontinent, including the mountainous terrain of Nepal. Additionally, the plant is well-established within Pakistan and the scenic landscapes of the West Himalaya. This wide distribution highlights the adaptability of the species across varying Asian climates.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Aquilegia pubiflora is a self-supporting plant that characterizes its environment through its distinct herb growth form. This resilient botanical structure allows the species to maintain its upright presence without the need for external support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Aquilegia pubiflora, commonly known as the Himalayan Columbine, has demonstrated significant pharmacological potential through recent phytochemical investigations. Scientific evaluations of various leaf extracts reveal that the plant possesses potent antimicrobial activity against strains such as K. pneumonia and A. niger. Furthermore, the plant exhibits strong antioxidant properties, with ethanol extracts showing high efficacy in multiple assays. Research also highlights its considerable cytotoxic potential, specifically showing significant cell inhibition against HepG2 cells. These diverse biological activities suggest that Aquilegia pubiflora could serve as a valuable foundation for developing novel medicinal drugs.
Compounds
Aquilegia pubiflora, commonly known as the Himalayan Columbine, has been identified as a rich source of various bioactive phytochemicals. Recent HPLC analysis of its leaf extracts has confirmed the presence of several important compounds, including chlorogenic acid and sinapic acid. Furthermore, the plant contains significant levels of flavones such as orientin, isoorientin, and isovitexin. These specific constituents contribute to the plant's diverse pharmacological potential, ranging from antioxidant to anti-inflammatory effects. Such findings highlight the medicinal importance of these chemical relationships in the development of future therapeutic drugs.
Conditions
Preparations
Aquilegia pubiflora is processed into various leaf extracts to facilitate pharmacological investigation. These leaf extracts are specifically prepared as distilled water APDW, methanol APM, ethanol APE, and ethyl acetate APEA. Each preparation utilizes solvents of different polarities to evaluate their respective bioactivities. Through these different preparation methods, the medicinal potential of the plant can be thoroughly assessed. Consequently, the diverse forms of APDW, APM, APE, and APEA serve as the primary candidates for determining optimal therapeutic effects.
Parts used
Aquilegia pubiflora, commonly known as the Himalayan Columbine, is a medicinal plant with a long history of traditional use for treating various human ailments. Recent scientific investigations have focused specifically on the pharmacological potential of the plant's leaf extracts. By utilizing solvents of varying polarities, researchers were able to isolate key phytochemical constituents such as dvitexin and ferulic acid from these leaves. The resulting extracts demonstrated remarkable bioactivities, including significant antimicrobial, antioxidant, and anti-inflammatory effects. These findings suggest that the leaf components of Aquilegia pubiflora hold great promise for the future development of novel therapeutic drugs.